Read more stories about
Montana Business >>

MATR Sponsor:

MATR Supporters:

Bozeman, Montana's SiteOne Therapeutics working on alternative opioid treatment receives $1 million grant

November 8, 2017View for printing

A Bozeman biotech company announced Tuesday it received a $1 million federal grant to continue its work developing a pain medication alternative to opioids.

The company, SiteOne Therapeutics , is currently developing a drug that effectively blocks pain signals to the brain. SiteOne's founders have said the treatment would be a welcome alternative to opioid painkillers such as oxycodone and fentanyl, which have adverse side effects including dependency and addiction.

The grant money was awarded through an R&D arm of the U.S. Department of Defense.

By Lewis Kendall Chronicle Staff Writer ... 8aa345.html
No reader comments so far. Be the first to comment by clicking the button below.

Reprinted under the Fair Use doctrine of international copyright law. Full copyright retained by the original publication. In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes.

E-mail this page to a friend!